Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a …

…, M Cervantes, MJ Amengual, M Navarro, A Payeras… - The Lancet …, 2021 - thelancet.com
Background Factors affecting outcomes of SARS-CoV-2 infection in people living with HIV
are unclear. We assessed the factors associated with SARS-CoV-2 diagnosis and severe …

Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir …

…, R Palacios, JA Iribarren, A Payeras… - Clinical Infectious …, 2017 - academic.oup.com
Background Our objective was to assess the therapeutic noninferiority of dual therapy with
darunavir/ritonavir and lamivudine compared to triple therapy with darunavir/ritonavir plus 2 …

[HTML][HTML] Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study

…, M Aranda, A Del Castillo, A Socias, A Payeras… - Microorganisms, 2020 - mdpi.com
There is limited information available describing the clinical and epidemiological features of
Spanish patients requiring hospitalization for coronavirus disease 2019 (COVID-19). In this …

[PDF][PDF] Randomized trial comparing pegylated interferon α‐2b versus pegylated interferon α‐2a, both plus ribavirin, to treat chronic hepatitis C in human …

…, J Murillas, S Veloso, M Larrousse, A Payeras… - …, 2009 - Wiley Online Library
Although two pegylated interferons (Peg‐IFN) are available to treat chronic hepatitis C virus
(HCV) infection, no head‐to‐head comparative studies have been published. We aim to …

Polyserositis: a diagnostic challenge

…, M García‐Gasalla, A Payeras - Internal Medicine …, 2018 - Wiley Online Library
Background Polyserositis (PS) is the inflammation, with effusion, of different serous
membranes. It has been associated with different aetiologies, but the aetiology of PS remains …

Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A (H1N1) virus infection

…, J Pachón, M Riera, F López-Medrano, A Payeras… - Chest, 2011 - Elsevier
Background Data on the clinical effectiveness of oseltamivir in patients with pandemic 2009
influenza A(H1N1) (A[H1N1]) virus infection are scarce. We aimed to determine the effect of …

The role of mannose-binding lectin in pneumococcal infection

…, FR de Castro, J Solé-Violán, A Payeras… - European …, 2013 - Eur Respiratory Soc
The role of mannose-binding lectin (MBL) deficiency (MBL2; XA/O and O/O genotypes) in
host defences remains controversial. The surfactant proteins (SP)-A1, -A2 and -D, other …

Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study

M Penaranda, V Falco, A Payeras… - Clinical Infectious …, 2007 - academic.oup.com
Background. Polysaccharide pneumococcal vaccine (PPV) is recommended among human
immunodeficiency virus (HIV)–infected patients, although its effect in reducing the incidence …

Kinetic analysis of the conversion of nonheme (alkylperoxo) iron (III) species to iron (IV) complexes

MP Jensen, AM Payeras, AT Fiedler, M Costas… - Inorganic …, 2007 - ACS Publications
Low-spin mononuclear (alkylperoxo)iron(III) complexes decompose by peroxide O−O bond
homolysis to form iron(IV) species. We examined the kinetics of previously reported …

[HTML][HTML] DOLAVI real-life study of dolutegravir plus lamivudine in naive HIV-1 patients (48 weeks)

…, S Ferra, A Terrón, I SanJoaquín, A Payeras… - Viruses, 2022 - mdpi.com
Brief: Real-world data in naïve HIV-1 patients demonstrate that dolutegravir plus lamivudine
in a multiple tablet regimen is effective, safe, and satisfactory; it causes moderately …